WHO expects to review Chinese vaccines on April 26 - official
WHO expects to review Chinese vaccines on April 26 - official
GENEVA, April 9 (Reuters) - China&aposs COVID-19 vaccines, made by Sinopharm and Sinovac SVA.O , are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.
A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.
WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine&aposs safety and efficacy.
GENEVA, April 9 (Reuters) - China&aposs COVID-19 vaccines, made by Sinopharm and Sinovac SVA.O , are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.
A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.
他説，第二次會議計劃在5月3日的那一周舉行，屆時將根據需要審查第二次會議。
WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine&aposs safety and efficacy.
世衞組織緊急使用清單是被Covax疫苗共享機構購買的先決條件，也是向監管機構較弱的國家發出的關於疫苗&APOSS安全性和有效性的信號。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧